• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4619882)   Today's Articles (196)   Subscriber (49404)
For: Barril X, Brough P, Drysdale M, Hubbard RE, Massey A, Surgenor A, Wright L. Structure-based discovery of a new class of Hsp90 inhibitors. Bioorg Med Chem Lett 2005;15:5187-91. [PMID: 16202589 DOI: 10.1016/j.bmcl.2005.08.092] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2005] [Revised: 08/11/2005] [Accepted: 08/22/2005] [Indexed: 12/01/2022]
Number Cited by Other Article(s)
1
Malami I, Bunza AM, Alhassan AM, Muhammad A, Abubakar IB, Yunusa A, Waziri PM, Etti IC. Dihydroartemisinin as a potential drug candidate for cancer therapy: a structural-based virtual screening for multitarget profiling. J Biomol Struct Dyn 2020;40:1347-1362. [PMID: 32964804 DOI: 10.1080/07391102.2020.1824811] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
2
Heat Shock Protein 90 (Hsp90)-Inhibitor-Luminespib-Loaded-Protein-Based Nanoformulation for Cancer Therapy. Polymers (Basel) 2020;12:polym12081798. [PMID: 32796651 PMCID: PMC7465148 DOI: 10.3390/polym12081798] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 08/05/2020] [Accepted: 08/07/2020] [Indexed: 01/08/2023]  Open
3
Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton: Promising antibreast cancer agent. Bioorg Chem 2020;101:103987. [DOI: 10.1016/j.bioorg.2020.103987] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Revised: 05/23/2020] [Accepted: 05/29/2020] [Indexed: 11/18/2022]
4
Koca İ, Yiğitcan S, Gümüş M, Gökce H, Sert Y. A new series of sulfa drugs containing pyrazolyl acylthiourea moiety: Synthesis, experimental and theoretical spectral characterization and molecular docking studies. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2019.127479] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
5
Yan F, Liu X, Zhang S, Zhang Q, Chen J. Understanding conformational diversity of heat shock protein 90 (HSP90) and binding features of inhibitors to HSP90 via molecular dynamics simulations. Chem Biol Drug Des 2019;95:87-103. [PMID: 31560152 DOI: 10.1111/cbdd.13623] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2019] [Revised: 08/06/2019] [Accepted: 08/26/2019] [Indexed: 12/23/2022]
6
Kim HH, Hyun JS, Choi J, Choi KE, Jee JG, Park SJ. Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain. Sci Rep 2018;8:368. [PMID: 29321504 PMCID: PMC5762686 DOI: 10.1038/s41598-017-18332-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2017] [Accepted: 12/08/2017] [Indexed: 12/17/2022]  Open
7
Blinded predictions of binding modes and energies of HSP90-α ligands for the 2015 D3R grand challenge. Bioorg Med Chem 2016;24:4890-4899. [DOI: 10.1016/j.bmc.2016.07.044] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Revised: 07/19/2016] [Accepted: 07/20/2016] [Indexed: 01/14/2023]
8
Al-Sha'er MA, Mansi I, Khanfar M, Abudayyh A. Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation. J Enzyme Inhib Med Chem 2016;31:64-77. [DOI: 10.1080/14756366.2016.1218485] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]  Open
9
Regulation of calreticulin-major histocompatibility complex (MHC) class I interactions by ATP. Proc Natl Acad Sci U S A 2015;112:E5608-17. [PMID: 26420867 DOI: 10.1073/pnas.1510132112] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
10
Kumalo HM, Bhakat S, Soliman ME. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective. Chem Biol Drug Des 2015;86:1131-60. [PMID: 25958815 DOI: 10.1111/cbdd.12582] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
11
Brandvold KR, Morimoto RI. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis. J Mol Biol 2015;427:2931-47. [PMID: 26003923 DOI: 10.1016/j.jmb.2015.05.010] [Citation(s) in RCA: 76] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2015] [Revised: 05/09/2015] [Accepted: 05/13/2015] [Indexed: 12/14/2022]
12
rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput Biol 2014;10:e1003571. [PMID: 24722481 PMCID: PMC3983074 DOI: 10.1371/journal.pcbi.1003571] [Citation(s) in RCA: 325] [Impact Index Per Article: 32.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2013] [Accepted: 02/19/2014] [Indexed: 11/19/2022]  Open
13
Aeluri M, Chamakuri S, Dasari B, Guduru SKR, Jimmidi R, Jogula S, Arya P. Small Molecule Modulators of Protein–Protein Interactions: Selected Case Studies. Chem Rev 2014;114:4640-94. [DOI: 10.1021/cr4004049] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
14
Brasca MG, Mantegani S, Amboldi N, Bindi S, Caronni D, Casale E, Ceccarelli W, Colombo N, De Ponti A, Donati D, Ermoli A, Fachin G, Felder ER, Ferguson RD, Fiorelli C, Guanci M, Isacchi A, Pesenti E, Polucci P, Riceputi L, Sola F, Visco C, Zuccotto F, Fogliatto G. Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90). Bioorg Med Chem 2013;21:7047-63. [DOI: 10.1016/j.bmc.2013.09.018] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2013] [Revised: 09/04/2013] [Accepted: 09/06/2013] [Indexed: 12/27/2022]
15
Meiby E, Simmonite H, le Strat L, Davis B, Matassova N, Moore JD, Mrosek M, Murray J, Hubbard RE, Ohlson S. Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90. Anal Chem 2013;85:6756-66. [DOI: 10.1021/ac400715t] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
16
Lauria A, Abbate I, Gentile C, Angileri F, Martorana A, Almerico AM. Synthesis and biological activities of a new class of heat shock protein 90 inhibitors, designed by energy-based pharmacophore virtual screening. J Med Chem 2013;56:3424-8. [PMID: 23520985 DOI: 10.1021/jm4002023] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
17
Analysis of structure-based virtual screening studies and characterization of identified active compounds. Future Med Chem 2012;4:603-13. [PMID: 22458680 DOI: 10.4155/fmc.12.18] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]  Open
18
Al-Sha'er MA, Taha MO. Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors. J Mol Model 2012;18:4843-63. [PMID: 22707278 DOI: 10.1007/s00894-012-1479-z] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2012] [Accepted: 05/21/2012] [Indexed: 12/23/2022]
19
Buchstaller HP, Eggenweiler HM, Sirrenberg C, Grädler U, Musil D, Hoppe E, Zimmermann A, Schwartz H, März J, Bomke J, Wegener A, Wolf M. Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90. Bioorg Med Chem Lett 2012;22:4396-403. [PMID: 22632933 DOI: 10.1016/j.bmcl.2012.04.121] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2012] [Revised: 04/26/2012] [Accepted: 04/29/2012] [Indexed: 12/22/2022]
20
Kang H, Sheng Z, Zhu R, Huang Q, Liu Q, Cao Z. Virtual drug screen schema based on multiview similarity integration and ranking aggregation. J Chem Inf Model 2012;52:834-43. [PMID: 22332590 DOI: 10.1021/ci200481c] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
21
Jackson SE. Hsp90: structure and function. Top Curr Chem (Cham) 2012;328:155-240. [PMID: 22955504 DOI: 10.1007/128_2012_356] [Citation(s) in RCA: 188] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
22
Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors. Eur J Med Chem 2011;46:2937-47. [DOI: 10.1016/j.ejmech.2011.04.018] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2011] [Revised: 03/30/2011] [Accepted: 04/04/2011] [Indexed: 11/19/2022]
23
Roughley SD, Hubbard RE. How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90. J Med Chem 2011;54:3989-4005. [DOI: 10.1021/jm200350g] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
24
Patel HJ, Modi S, Chiosis G, Taldone T. Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment. Expert Opin Drug Discov 2011;6:559-587. [PMID: 22400044 DOI: 10.1517/17460441.2011.563296] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
25
Doddareddy MR, Thorat DA, Seo SH, Hong TJ, Cho YS, Hahn JS, Pae AN. Structure based design of heat shock protein 90 inhibitors acting as anticancer agents. Bioorg Med Chem 2011;19:1714-20. [PMID: 21306907 DOI: 10.1016/j.bmc.2011.01.023] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2010] [Revised: 01/12/2011] [Accepted: 01/13/2011] [Indexed: 01/06/2023]
26
Al-Sha'er MA, Taha MO. Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors. J Chem Inf Model 2011;50:1706-23. [PMID: 20831219 DOI: 10.1021/ci100222k] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
27
Roughley S, Wright L, Brough P, Massey A, Hubbard RE. Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening. Top Curr Chem (Cham) 2011;317:61-82. [DOI: 10.1007/128_2011_181] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
28
Sheikha GA, Al-Sha'er MA, Taha MO. Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation. J Enzyme Inhib Med Chem 2010;26:603-9. [PMID: 21190426 DOI: 10.3109/14756366.2010.541394] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]  Open
29
In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B. Bioorg Med Chem Lett 2010;20:958-62. [DOI: 10.1016/j.bmcl.2009.12.060] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2009] [Revised: 12/11/2009] [Accepted: 12/14/2009] [Indexed: 11/18/2022]
30
Saxena AK, Saxena S, Chaudhaery SS. Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors. SAR AND QSAR IN ENVIRONMENTAL RESEARCH 2010;21:1-20. [PMID: 20373211 DOI: 10.1080/10629360903560504] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
31
Hahn JS. The Hsp90 chaperone machinery: from structure to drug development. BMB Rep 2009;42:623-30. [DOI: 10.5483/bmbrep.2009.42.10.623] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
32
Brough PA, Barril X, Borgognoni J, Chene P, Davies NGM, Davis B, Drysdale MJ, Dymock B, Eccles SA, Garcia-Echeverria C, Fromont C, Hayes A, Hubbard RE, Jordan AM, Jensen MR, Massey A, Merrett A, Padfield A, Parsons R, Radimerski T, Raynaud FI, Robertson A, Roughley SD, Schoepfer J, Simmonite H, Sharp SY, Surgenor A, Valenti M, Walls S, Webb P, Wood M, Workman P, Wright L. Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone. J Med Chem 2009;52:4794-809. [PMID: 19610616 DOI: 10.1021/jm900357y] [Citation(s) in RCA: 129] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
33
Sgobba M, Rastelli G. Structure-Based and in silico Design of Hsp90 Inhibitors. ChemMedChem 2009;4:1399-409. [DOI: 10.1002/cmdc.200900256] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
34
Feldman RI, Mintzer B, Zhu D, Wu JM, Biroc SL, Yuan S, Emayan K, Chang Z, Chen D, Arnaiz DO, Bryant J, Ge XS, Whitlow M, Adler M, Polokoff MA, Li WW, Ferrer M, Sato T, Gu JM, Shen J, Tseng JL, Dinter H, Buckman B. Potent triazolothione inhibitor of heat-shock protein-90. Chem Biol Drug Des 2009;74:43-50. [PMID: 19519743 DOI: 10.1111/j.1747-0285.2009.00833.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
35
Lauria A, Ippolito M, Almerico AM. Principal component analysis on molecular descriptors as an alternative point of view in the search of new Hsp90 inhibitors. Comput Biol Chem 2009;33:386-90. [PMID: 19660987 DOI: 10.1016/j.compbiolchem.2009.07.010] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2008] [Revised: 07/06/2009] [Accepted: 07/16/2009] [Indexed: 01/01/2023]
36
Hong TJ, Park H, Kim YJ, Jeong JH, Hahn JS. Identification of new Hsp90 inhibitors by structure-based virtual screening. Bioorg Med Chem Lett 2009;19:4839-42. [PMID: 19560353 DOI: 10.1016/j.bmcl.2009.06.040] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2009] [Revised: 05/27/2009] [Accepted: 06/10/2009] [Indexed: 11/30/2022]
37
Barker J, Barker O, Boggio R, Chauhan V, Cheng RK, Corden V, Courtney S, Edwards N, Falque V, Fusar F, Gardiner M, Hamelin EM, Hesterkamp T, Ichihara O, Jones R, Mather O, Mercurio C, Minucci S, Montalbetti CA, Müller A, Patel D, Phillips B, Varasi M, Whittaker M, Winkler D, Yarnold C. Fragment-based Identification of Hsp90 Inhibitors. ChemMedChem 2009;4:963-6. [DOI: 10.1002/cmdc.200900011] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
38
Knox AJS, Price T, Pawlak M, Golfis G, Flood CT, Fayne D, Williams DC, Meegan MJ, Lloyd DG. Integration of ligand and structure-based virtual screening for the identification of the first dual targeting agent for heat shock protein 90 (Hsp90) and tubulin. J Med Chem 2009;52:2177-80. [PMID: 19331414 DOI: 10.1021/jm801569z] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
39
Thepchatri P, Min J, Ganesh T, Du Y, Lewis I, Kurtkaya S, Prussia A, Li L, Plemper RK, Fu H, Liotta DC, Snyder JP, Dingledine R, Sun A. Cancer and virus leads by HTS, chemical design and SEA data mining. Curr Top Med Chem 2009;9:1159-71. [PMID: 19807668 PMCID: PMC4442615 DOI: 10.2174/156802609789753581] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2008] [Accepted: 10/18/2008] [Indexed: 11/22/2022]
40
Hadden MK, Hill SA, Davenport J, Matts RL, Blagg BSJ. Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold. Bioorg Med Chem 2008;17:634-40. [PMID: 19101151 DOI: 10.1016/j.bmc.2008.11.064] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2008] [Revised: 11/20/2008] [Accepted: 11/24/2008] [Indexed: 12/18/2022]
41
Lauria A, Ippolito M, Almerico AM. Inside the Hsp90 inhibitors binding mode through induced fit docking. J Mol Graph Model 2008;27:712-22. [PMID: 19084447 DOI: 10.1016/j.jmgm.2008.11.004] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2008] [Revised: 10/01/2008] [Accepted: 11/03/2008] [Indexed: 12/29/2022]
42
Taldone T, Sun W, Chiosis G. Discovery and development of heat shock protein 90 inhibitors. Bioorg Med Chem 2008;17:2225-35. [PMID: 19017562 DOI: 10.1016/j.bmc.2008.10.087] [Citation(s) in RCA: 117] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2008] [Revised: 10/18/2008] [Accepted: 10/31/2008] [Indexed: 12/18/2022]
43
Green DVS. Virtual screening of chemical libraries for drug discovery. Expert Opin Drug Discov 2008;3:1011-26. [DOI: 10.1517/17460441.3.9.1011] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
44
Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay. Bioorg Med Chem Lett 2008;18:4982-7. [PMID: 18762423 DOI: 10.1016/j.bmcl.2008.08.022] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2008] [Revised: 08/06/2008] [Accepted: 08/08/2008] [Indexed: 01/15/2023]
45
Ganesh T, Min J, Thepchatri P, Du Y, Li L, Lewis I, Wilson L, Fu H, Chiosis G, Dingledine R, Liotta D, Snyder JP, Sun A. Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling. Bioorg Med Chem 2008;16:6903-10. [PMID: 18571929 DOI: 10.1016/j.bmc.2008.05.047] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2008] [Revised: 05/08/2008] [Accepted: 05/22/2008] [Indexed: 12/29/2022]
46
Burlison JA, Avila C, Vielhauer G, Lubbers DJ, Holzbeierlein J, Blagg BSJ. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. J Org Chem 2008;73:2130-7. [PMID: 18293999 DOI: 10.1021/jo702191a] [Citation(s) in RCA: 98] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
47
Waszkowycz B. Towards improving compound selection in structure-based virtual screening. Drug Discov Today 2008;13:219-26. [PMID: 18342797 DOI: 10.1016/j.drudis.2007.12.002] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2007] [Revised: 12/06/2007] [Accepted: 12/15/2007] [Indexed: 10/22/2022]
48
Park H, Kim YJ, Hahn JS. A novel class of Hsp90 inhibitors isolated by structure-based virtual screening. Bioorg Med Chem Lett 2007;17:6345-9. [PMID: 17869098 DOI: 10.1016/j.bmcl.2007.08.069] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2007] [Revised: 08/27/2007] [Accepted: 08/29/2007] [Indexed: 01/22/2023]
49
Shen G, Wang M, Welch TR, Blagg BSJ. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90. J Org Chem 2007;71:7618-31. [PMID: 16995666 DOI: 10.1021/jo061054f] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
50
Richardson CM, Nunns CL, Williamson DS, Parratt MJ, Dokurno P, Howes R, Borgognoni J, Drysdale MJ, Finch H, Hubbard RE, Jackson PS, Kierstan P, Lentzen G, Moore JD, Murray JB, Simmonite H, Surgenor AE, Torrance CJ. Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping. Bioorg Med Chem Lett 2007;17:3880-5. [PMID: 17570665 DOI: 10.1016/j.bmcl.2007.04.110] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2007] [Revised: 04/30/2007] [Accepted: 04/30/2007] [Indexed: 11/16/2022]
PrevPage 1 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA